Why GLP-1 side effects need context A side effect by itself is only part of the story
Read the analysis: Michael Weintraub, MD Neil Iyengar Stephen Nicholls To view or add a comment, sign in New commentary from American Association of Clinical Endocrinology (AACE) president Scott Isaacs, MD, FACP, FACE, examines the full SURPASS-CVOT dataset published in NEJM Group and shares his thoughts on what the findings mean for cardiometabolic care in patients with type 2 diabetes and established ASCVD
We see this with some other disease states
These cells function as presynaptic cells that form conventional neuronal synapses with sensory afferent nerve fibers, releasing serotonin, norepinephrine, and GABA as neurotransmitters (51, 52)
[DOI] [PMC free article] [PubMed] [Google Scholar] 33.Meier J.J., Menge B.A., Schenker N., Erdmann S., Kahle-Stephan M., Schliess F
In addition, clinical studies with GLP-1 peptide or its receptor agonists have also pointed toward a potential role for this hormone in influencing sodium homeostasis